Additionally, it could be argued that the relationship between inflammation and PD-L1/PD-1 expression supports the effectiveness of anti-PD/PD-L treatment, as it has been established that both a higher degree of inflammation and elevated PD-L1/PD-1 levels were prevalent in both OSCC and T-OLP. This evidence concerns the gene CD274 and oral lichen planus.